This inventor holds 9 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Novozymes A/s, Novozymes A/s of Krogshoejvej 36. Active years: 2004-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bagsværd, DK (2004)
- Bagsvaerd, DK (2010 - 2019)
Company Filing History:
Years Active: 2004-2019
Title: Innovations and Contributions of Carsten Lillelund Olsen
Introduction
Carsten Lillelund Olsen, an innovative inventor based in Bagsvaerd, Denmark, has made significant contributions to the field of biotechnology. With a total of nine patents to his name, he stands out as a notable figure in developing recombinant fungal host cells, showcasing his expertise in genetic engineering.
Latest Patents
One of Olsen's latest inventions focuses on a method for constructing a recombinant fungal host cell. This invention entails transforming a fungal host cell with an integrative polynucleotide construct that includes a selectable marker polynucleotide and another encoding a polypeptide of interest. The unique aspect of this method involves the inclusion of a spliceosomal intron, specifically one that has five nucleotides or fewer between its branch site and acceptor site. This innovative approach not only enhances the construction of recombinant cells but also opens avenues for effective polynucleotide constructs and methods of manufacture.
Career Highlights
Throughout his career, Carsten Lillelund Olsen has been associated with prominent biotechnology companies, notably Novozymes A/S, located at Krogshoejvej 36. His work has consistently revolved around developing and improving biotechnological processes and applications, solidifying his role as a leader in the industry.
Collaborations
Olsen has collaborated with skilled professionals such as Michael Dolberg Rasmussen and Jesper Vind. These collaborations have likely contributed to further advancements in research and the successful implementation of innovative solutions in his projects.
Conclusion
Carsten Lillelund Olsen's dedication to innovation in biotechnology is evidenced by his numerous patents and significant collaborations. His latest inventions reflect a commitment to advancing genetic engineering and contribute to the future of recombinant technology, making him a prominent figure in the realm of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile